Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03931538 · ClinicalTrials.gov registry record · NA
Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study
A NA study of Urinary Tract Infections and Interstitial Cystitis, sponsored by Pathnostics.
- Completed
- Registry status
- NA
- Development phase
- 2,511
- Enrollment target
- 1
- Study location
NCT03931538 is a NA study of Urinary Tract Infections and Interstitial Cystitis that has completed, run by Pathnostics. The registered enrollment target is 2,511 participants, above the 384-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (554% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03931538, a NA study of Urinary Tract Infections and Interstitial Cystitis, has completed, sponsored by Pathnostics.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,511 participants
- Enrollment target
- 1
- Study location
Study Summary
In this protocol, investigators are examining the ability for a novel multiplex PCR assay with mixed floral antibiotic resistance profiling is safe and increases effective treatment for urinary tract infections in a urology clinic over traditional culture methods alone and decreases retreatment rates in this population.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Urine Culture
- DIAGNOSTIC_TEST Guidance 4.0 PCR test
Study Locations (1)
Michigan
- Comprehensive Urology - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,511 participants |
| Start Date | 2018-07-17 |
| Est. Completion | 2019-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03931538
The ClinicalTrials.gov registry entry for NCT03931538 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,511 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 384-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (554% higher). The listed sponsor is Pathnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Urinary Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which Urine Culture is the first listed.
NCT03931538 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03931538 about?
NCT03931538 is a clinical study titled "Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study". In this protocol, investigators are examining the ability for a novel multiplex PCR assay with mixed floral antibiotic resistance profiling is safe and increases effective treatment for urinary tract infections in a urology clinic over traditional culture methods alone and decreases retreatment rate...
What is the current status of trial NCT03931538?
This trial is currently completed. It is a NA study. The enrollment target is 2,511 participants. The study started on 2018-07-17. Estimated completion is 2019-10-01.
What conditions does trial NCT03931538 study?
This clinical trial studies the following conditions: Urinary Tract Infections, Interstitial Cystitis, Prostatitis.
What interventions are being tested in trial NCT03931538?
The interventions under investigation include: Urine Culture (DIAGNOSTIC_TEST), Guidance 4.0 PCR test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03931538?
This trial is sponsored by Pathnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03931538 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Double Voiding and Post-transplant UTI
RECRUITING · NA
-
Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture
RECRUITING · NA
-
Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.